ICUREsearch’s mission is to provide support to the sponsors for designing and managing their clinical trials. ICUREsearch can discuss and design the most appropriate study design, execute the statistical analysis after having cleaned the data, and contribute to the results interpretation. ICUREsearch can ensure the medical writing of all your study-related documents, up the scientific publications.
We are pleased to announce that the SAS ICUREsearch obtained the CIR (crédit d'impôt recherche) for 2016-2017-2018.
In patients with invasive candidiasis, early antifungal therapy reduces mortality. In the absence of early accurate diagnostic tests, antifungal therapy is started empirically in the sickest patients with sepsis, risk factors of invasive fungal infections and multiple candida colonization. However, this strategy, recommended by recent 2016 IDSA guidelines never proved effectiveness in non-neutropenic non transplanted critically ill patients. Read more